WealthTrust-Arizona’s Insys Therapeutics, Inc. INSY Stock Holding History

WealthTrust-Arizona’s Portfolio INSY Stock Details INSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$1K	Hold	200	–	–	﹤0.01%	672
2018 Q3	$2K	Hold	200	–	–	﹤0.01%	626
2018 Q2	$1K	Hold	200	–	–	﹤0.01%	664
2018 Q1	$1K	Hold	200	–	–	﹤0.01%	639
2017 Q4	$2K	Hold	200	–	–	﹤0.01%	599
2017 Q3	$2K	Hold	200	–	–	﹤0.01%	602
2017 Q2	$3K	Hold	200	–	–	﹤0.01%	555
2017 Q1	$2K	Hold	200	–	–	﹤0.01%	566
2016 Q4	$2K	Hold	200	–	–	﹤0.01%	565
2016 Q3	$2K	Hold	200	–	–	﹤0.01%	561
2016 Q2	$3K	Hold	200	–	–	﹤0.01%	530
2016 Q1	$3K	Hold	200	–	–	﹤0.01%	526
2015 Q4	$6K	Hold	200	–	–	﹤0.01%	472
2015 Q3	$6K	Hold	200	–	–	﹤0.01%	456
2015 Q2	$7K	Hold	200	–	–	﹤0.01%	462
2015 Q1	$6K	Buy	+200	New	+$5.29K	﹤0.01%	500
2014 Q3	–	Sell	-600	Closed	-$9K	–	670
2014 Q2	$9K	Buy	+600	New	+$9.7K	0.01%	427

Other funds holding INSY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

WealthTrust-Arizona's INSY Position: Q4 2018 in Review

WealthTrust-Arizona held its Insys Therapeutics, Inc. (INSY) position steady in Q4 2018 at 200 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #672.

WealthTrust-Arizona first reported a position in INSY in Q2 2014 and has held it in 17 quarters since. The position peaked at $9K in Q2 2014. 113 funds tracked by Wall St. Rank hold INSY as of Q4 2018.

WealthTrust-Arizona held 200 shares of Insys Therapeutics, Inc. worth $1K as of Q4 2018.
WealthTrust-Arizona left its Insys Therapeutics, Inc. share count unchanged in Q4 2018.
Insys Therapeutics, Inc. made up ﹤0.01% of WealthTrust-Arizona's portfolio in Q4 2018, its #672 holding.
WealthTrust-Arizona first reported a position in Insys Therapeutics, Inc. in Q2 2014 and has held it in 17 quarters since.
WealthTrust-Arizona's Insys Therapeutics, Inc. position peaked at $9K in Q2 2014.
113 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q4 2018.

Based on WealthTrust-Arizona's 13F filing for Q4 2018, filed 7 Feb 2019.